Jazz Pharmaceuticals plc — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
15-12B
3
3/A
4
4/A
424B3
424B4
424B5
424B7
425
5
8-A12B
8-K
8-K/A
8-K12B
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEFM14A
DFAN14A
EFFECT
FWP
IRANNOTICE
NO ACT
POS AM
PRE 14A
PREM14A
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-3
S-3ASR
S-3MEF
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-T
SC TO-T/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| UPLOAD | — | 0000000000-25-007583 | Jul 17, 2025 | — |
| DEFA14A | DEFA14A | 0001193125-25-158729 | Jul 14, 2025 | — |
| DEFA14A | DEFA14A | 0001193125-25-157389 | Jul 10, 2025 | — |
| 8-K | 8-K | 0001193125-25-157388 | Jul 10, 2025 | Jul 8, 2025 |
| 4 | PRIMARY DOCUMENT | 0001765581-25-000046 | Jul 3, 2025 | Jul 1, 2025 |
| 144 | — | 0002007317-25-000663 | Jul 1, 2025 | — |
| DEF 14A | DEF 14A | 0001232524-25-000043 | Jun 6, 2025 | Jul 24, 2025 |
| DEFA14A | DEFA14A | 0001232524-25-000044 | Jun 6, 2025 | — |
| ARS | ARS | 0001232524-25-000045 | Jun 6, 2025 | Dec 31, 2024 |
| 4 | PRIMARY DOCUMENT | 0001765581-25-000044 | Jun 4, 2025 | Jun 2, 2025 |
| 144 | — | 0002007317-25-000485 | Jun 2, 2025 | — |
| PRE 14A | PRE 14A | 0001232524-25-000033 | May 23, 2025 | Jul 24, 2025 |
| 4 | PRIMARY DOCUMENT | 0001765581-25-000042 | May 13, 2025 | May 9, 2025 |
| 10-Q | 10-Q | 0001232524-25-000027 | May 7, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001232524-25-000025 | May 6, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001765581-25-000039 | May 5, 2025 | May 1, 2025 |
| 144 | — | 0002007317-25-000275 | May 1, 2025 | — |
| 10-K/A | 10-K/A | 0001232524-25-000014 | Apr 25, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001193125-25-087233 | Apr 21, 2025 | — |
| SC TO-T/A | SC TO-T/A | 0001193125-25-084918 | Apr 18, 2025 | — |
| SC TO-T/A | SC TO-T/A | 0001193125-25-080260 | Apr 14, 2025 | — |
| SC TO-T/A | SC TO-T/A | 0001193125-25-079177 | Apr 11, 2025 | — |
| SC TO-T/A | SC TO-T/A | 0001193125-25-077414 | Apr 10, 2025 | — |
| SC TO-T/A | SC TO-T/A | 0001193125-25-076865 | Apr 9, 2025 | — |
| 8-K | 8-K | 0001193125-25-075871 | Apr 8, 2025 | Apr 7, 2025 |
| SC TO-T/A | SC TO-T/A | 0001193125-25-074011 | Apr 7, 2025 | — |
| CORRESP | — | 0001193125-25-072946 | Apr 4, 2025 | — |
| SC TO-T/A | SC TO-T/A | 0001193125-25-072944 | Apr 4, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001765581-25-000037 | Apr 3, 2025 | Apr 1, 2025 |
| SC TO-T/A | SC TO-T/A | 0001193125-25-070464 | Apr 1, 2025 | — |
| 144 | — | 0001971857-25-000161 | Apr 1, 2025 | — |
| SC TO-T/A | SC TO-T/A | 0001193125-25-066330 | Mar 28, 2025 | — |
| SC TO-T | SC TO-T | 0001193125-25-059729 | Mar 21, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001765581-25-000035 | Mar 12, 2025 | Mar 10, 2025 |
| 4 | PRIMARY DOCUMENT | 0001765581-25-000033 | Mar 11, 2025 | Mar 7, 2025 |
| 4 | PRIMARY DOCUMENT | 0001765581-25-000031 | Mar 11, 2025 | Mar 7, 2025 |
| 144 | — | 0001972362-25-000266 | Mar 10, 2025 | — |
| 144 | — | 0001972362-25-000268 | Mar 10, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001765581-25-000024 | Mar 7, 2025 | Mar 5, 2025 |
| 144 | — | 0001950047-25-001676 | Mar 7, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001765581-25-000027 | Mar 7, 2025 | Mar 5, 2025 |
| 144 | — | 0001765581-25-000022 | Mar 7, 2025 | — |
| 144 | — | 0001972362-25-000255 | Mar 7, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001765581-25-000028 | Mar 7, 2025 | Mar 5, 2025 |
| 4 | PRIMARY DOCUMENT | 0001765581-25-000029 | Mar 7, 2025 | Mar 5, 2025 |
| 4 | PRIMARY DOCUMENT | 0001765581-25-000025 | Mar 7, 2025 | Mar 5, 2025 |
| 4 | PRIMARY DOCUMENT | 0001765581-25-000026 | Mar 7, 2025 | Mar 5, 2025 |
| SC TO-C | SC TO-C | 0001193125-25-048464 | Mar 6, 2025 | — |
| SC TO-C | SC TO-C | 0001193125-25-047198 | Mar 5, 2025 | — |
| SC TO-C | SC TO-C | 0001193125-25-047301 | Mar 5, 2025 | — |